Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank 薬物名（臨床試験情報から抽出） KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Folic acid 💬1件: Folic acid5件: Acide folique; Folate; Folic Acid; Multivitamin; Nicotinamide--6件: 6, 41, 46, 49, 84, 296 💬
2 Noradrenaline 💬1件: Norepinephrine2件: Norepinephrine; Norepinephrine Bitartrate9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 22, 296 💬
3 Vancomycin 💬1件: Vancomycin1件: Vancomycin--8件: 13, 46, 70, 94, 96, 97, 296, 299 💬
4 Acetylcysteine 💬1件: Acetylcysteine3件: Acetylcysteine; Mucomyst; N-Acetylcysteine--21件: 6, 13, 19, 20, 21, 49, 51, 53, 58, 63, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337 💬
5 Dexamethasone 💬1件: Dexamethasone5件: Decadron; Dexametasona; Dexamethasone; DEXAMETHASONE SODIUM PHOSPHATE; Maxidex1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬22件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
6 Methylprednisolone 💬1件: Methylprednisolone4件: Medrol; Methylprednisolon; Methylprednisolone; METHYLPREDNISOLONE ACETATE1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬46件: 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
7 Prednisolone 💬1件: Prednisolone3件: Prednisolona; PREDNISOLONE; Prednisolonum1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬42件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
8 Pentoxifylline 💬1件: Pentoxifylline1件: Pentoxifylline--12件: 26, 56, 84, 86, 93, 96, 97, 113, 220, 222, 296, 298 💬
9 Desflurane 💬1件: Desflurane1件: Desflurane--2件: 22, 296 💬
10 Sevoflurane 💬1件: Sevoflurane1件: Sevoflurane--7件: 6, 21, 22, 34, 98, 225, 296 💬
11 Propofol 💬1件: Propofol2件: PROPOFOL; Propofol Injection16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬8件: 6, 21, 22, 34, 46, 70, 98, 296 💬
12 Ursodiol 💬1件: Ursodeoxycholic acid4件: UDCA; Ursodeoxycholic Acid; Ursodiol; Ursofalk1件: NR1H4 💬 1件: Bile secretion 💬14件: 6, 8, 20, 46, 67, 84, 93, 94, 95, 96, 97, 234, 296, 299 💬
13 Meloxicam 💬1件: Meloxicam1件: Meloxicam1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬4件: 46, 49, 271, 296 💬
14 Magnesium sulfate 💬1件: Magnesium sulfate1件: Magnesium sulfate--3件: 11, 296, 297 💬
15 Indocyanine green 💬1件: Indocyanine green1件: Indocyanine Green--8件: 22, 46, 51, 96, 235, 278, 291, 296 💬
16 Bezafibrate 💬1件: Bezafibrate1件: BEZAFIBRATE1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬7件: 20, 93, 94, 160, 296, 316, 324 💬
17 Icosapent ethyl 💬1件: Icosapent ethyl2件: Ethyl-EPA; Icosapent--1件: 8 💬
18 Rifaximin 💬1件: Rifaximin3件: Rifaximin; RIFAXIMINA; Xifaxan--9件: 6, 65, 93, 94, 96, 97, 99, 296, 299 💬
19 Ammonia solution, strong 💬1件: Ammonia1件: Ammonia--2件: 6, 296 💬
20 Rituximab 💬1件: Rituximab6件: MABTHERA; Rituxan; RITUXIMAB; Rixathon; Ruxience; TRUXIMA1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬48件: 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
21 Belimumab 💬1件: Belimumab2件: Belimumab; Benlysta1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬13件: 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 💬
22 Filgrastim 💬1件: Filgrastim7件: Filgrastim; Filgrastim Hexal; G-CSF; Granulocyte Colony Stimulating Factor; Neupogen; TEVAGRASTIM; Zarzio1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬35件: 2, 6, 11, 13, 16, 22, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
23 Dimethyl fumarate 💬1件: Dimethyl fumarate3件: Dimethyl fumarate; Dimethylfumarat; TECFIDERA1件: KEAP1 💬 6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬5件: 13, 49, 51, 86, 296 💬
24 Lactobacillus casei 💬1件: Lactobacillus casei2件: Fusion; Lactobacillus casei--10件: 6, 11, 13, 46, 49, 69, 70, 97, 271, 296 💬
25 Magnesium gluconate 💬1件: Magnesium gluconate2件: Magnesium; Magnesium gluconate--2件: 296, 297 💬
26 Cefoperazone 💬1件: Cefoperazone1件: Cefoperazone--1件: 296 💬
27 Icosapent 💬1件: Icosapent2件: Eicosapentaenoic acid; Icosapent--7件: 8, 49, 96, 97, 296, 297, 338 💬
28 Neomycin 💬1件: Neomycin1件: Neomycin--3件: 96, 97, 296 💬
29 Propranolol 💬1件: Propranolol2件: Propanolol; Propranolol3件: ADRB1,
ADRB2,
ADRB3 💬 		12件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬6件: 6, 158, 167, 227, 278, 296 💬
30 Obeticholic acid 💬1件: Obeticholic acid4件: 6-ECDCA; 6-ethylchenodeoxycholic acid; Obeticholic Acid; Ocaliva1件: NR1H4 💬 1件: Bile secretion 💬3件: 93, 265, 296 💬
31 Maralixibat 💬1件: Maralixibat1件: Maralixibat2件: SLC10A1,
SLC10A2 💬 		2件: Bile secretion, Hepatitis B 💬3件: 296, 297, 338 💬
32 Odevixibat 💬1件: Odevixibat1件: Odevixibat1件: SLC10A2 💬 1件: Bile secretion 💬3件: 296, 297, 338 💬